Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review
- PMID: 21893008
Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review
Abstract
The use of serotonine reuptake inhibitors (SRIs) is increasing among Danish pregnant women. This systematic review addresses the potential adverse effects on the foetus and child of maternal SRI medication. The literature indicates a slightly increased risk of cardiovascular malformations and persistent pulmonary hypertension of the new-born, while evidence regarding the risk of preterm labour, low birth weight, low Apgar score, prolonged QT interval and miscarriage is less clear. An estimated 20-30% of infants will have neonatal symptoms following intrauterine SRI exposure. The symptoms may be caused by SRI withdrawal, toxicity or their overlap, but symptom aetiology basically remains controversial. The infants may exhibit neurological, gastrointestinal, autonomic, endocrine or respiratory symptoms. Although the symptoms are self-limited, the families may be seriously affected. In general, studies do not address this important aspect. Evidence concerning long-term effects is surprisingly sparse and many studies have important methodological limitations. However, present evidence does not convincingly indicate detrimental long-term effects. Until sufficient safety studies have been carried out, SRI must be used with caution in pregnancy and every treatment of the pregnant woman should be thoroughly considered.
Similar articles
-
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.
-
Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.BMJ Open. 2016 Nov 29;6(11):e013293. doi: 10.1136/bmjopen-2016-013293. BMJ Open. 2016. PMID: 27899401 Free PMC article.
-
[Selective serotonin reuptake inhibitors and pregnancy].Ugeskr Laeger. 2014 Feb 3;176(3):236-9. Ugeskr Laeger. 2014. PMID: 24629751 Review. Danish.
-
Serotonin reuptake inhibitor-induced perinatal complications.Paediatr Drugs. 2007;9(2):97-106. doi: 10.2165/00148581-200709020-00003. Paediatr Drugs. 2007. PMID: 17407365 Review.
-
Antidepressants in pregnancy: a systematic review.Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Aust N Z J Psychiatry. 2010. PMID: 21034181 Review.
Cited by
-
Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Eur Child Adolesc Psychiatry. 2014 Oct;23(10):973-92. doi: 10.1007/s00787-014-0558-3. Epub 2014 May 27. Eur Child Adolesc Psychiatry. 2014. PMID: 24863148 Review.
-
The Complexities Associated with Caring for Hospitalised Infants with Neonatal Abstinence Syndrome: The Perspectives of Nurses and Midwives.Children (Basel). 2021 Feb 17;8(2):152. doi: 10.3390/children8020152. Children (Basel). 2021. PMID: 33671297 Free PMC article.
-
A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring's outcomes.Arch Womens Ment Health. 2018 Apr;21(2):127-140. doi: 10.1007/s00737-017-0780-3. Epub 2017 Oct 12. Arch Womens Ment Health. 2018. PMID: 29027013 Free PMC article. Review.
-
The Physiology of Reproduction - Quo vadis?Front Physiol. 2021 Mar 30;12:650550. doi: 10.3389/fphys.2021.650550. eCollection 2021. Front Physiol. 2021. PMID: 33859571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
